Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial.
Olde Nordkamp LRA. et al, (2024), Circ Arrhythm Electrophysiol
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial.
Knops RE. et al, (2024), Circ Cardiovasc Qual Outcomes, 17
"Real-world" performance of the Confirm Rx™ SharpSense AF detection algorithm: UK Confirm Rx study.
Gala ABE. et al, (2024), J Arrhythm, 40, 1093 - 1101
Role of impedance drop and lesion size index (LSI) to guide catheter ablation for atrial fibrillation.
Leo M. et al, (2024), Pacing Clin Electrophysiol
The effect of sodium-glucose co-transporter 2 inhibitors on outcomes after cardiac resynchronization therapy.
Bray JJH. et al, (2024), ESC Heart Fail, 11, 2314 - 2322
Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure.
Singh JP. et al, (2024), JAMA Cardiol
Leveraging 3D Atrial Geometry for the Evaluation of Atrial Fibrillation: A Comprehensive Review
Sharp AJ. et al, (2024), Journal of Clinical Medicine, 13, 4442 - 4442
Left Atrial Appendage Occlusion: British Cardiovascular Intervention Society and British Heart Rhythm Society Position Statement
Betts TR. et al, (2024), Arrhythmia & Electrophysiology Review, 13
Left Atrial Appendage Occlusion: British Cardiovascular Intervention Society and British Heart Rhythm Society Position Statement
Betts TR. et al, (2024), Interventional Cardiology: Reviews, Research, Resources, 19
Cardiac resynchronization using fusion pacing during exercise.
Green PG. et al, (2023), J Cardiovasc Electrophysiol
What determines the optimal pharmacological treatment of atrial fibrillation? Insights from in silico trials in 800 virtual atria.
Dasí A. et al, (2023), J Physiol, 601, 4013 - 4032
Baseline left atrial low-voltage area predicts recurrence after pulmonary vein isolation: WAVE-MAP AF results.
Starek Z. et al, (2023), Europace, 25
Progress in atrial fibrillation ablation during 25 years of Europace journal.
Boersma L. et al, (2023), Europace, 25
Should lethal arrhythmias in hypertrophic cardiomyopathy be predicted using non-electrophysiological methods?
Saumarez R. et al, (2023), Europace, 25
Treatment of pathophysiologic propagation outside of the pulmonary veins in retreatment of atrial fibrillation patients: RECOVER AF study.
Betts TR. et al, (2023), Europace, 25
Real-world clinical outcomes with a next-generation left atrial appendage closure device: the FLXibility Post-Approval Study.
Betts TR. et al, (2023), Europace, 25, 914 - 921
Intracardiac Echocardiography to Guide Watchman FLX Implantation: The ICE LAA Study.
Nielsen-Kudsk JE. et al, (2023), JACC Cardiovasc Interv, 16, 643 - 651
'Pill-in-the-pocket' Oral Anticoagulation Guided by Daily Rhythm Monitoring for Stroke Prevention in Patients with AF: A Systematic Review and Meta-analysis.
Briosa E Gala A. et al, (2023), Arrhythm Electrophysiol Rev, 12